New hope for tough lung cancer cases: trial targets brain tumors after standard drugs fail
NCT ID NCT07343479
Summary
This study is testing whether adding a new drug called sac-TMT to a standard lung cancer pill, with or without brain radiation, can help control cancer that has spread to the brain after other similar pills have stopped working. It will involve about 45 adults with a specific type of advanced lung cancer (non-squamous NSCLC with an EGFR mutation). The main goal is to see if this combination can keep the cancer from getting worse for at least six months and to check how safe it is.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310022, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.